2026年4月18日 美国东部时间09:25 / 福克斯新闻
特朗普表示，该行政令将落实“历史性改革，大幅加快基于致幻剂的新型医学研究和治疗手段的可及性”
作者：格雷格·诺曼-戴蒙德 福克斯新闻
发布于2026年4月18日 美国东部时间上午9:25 | 更新于2026年4月18日 美国东部时间上午10:03
乔·罗根聚焦退伍军人心理健康后，特朗普加快FDA对致幻剂的审查流程
唐纳德·特朗普总统签署一项行政令，要求FDA加快对已被指定为突破性疗法的致幻剂的审查。乔·罗根等人在椭圆形办公室就该疗法对退伍军人心理健康的益处发表了讲话。
NEW 您现在可以收听福克斯新闻的文章！
收听本文
4分钟
唐纳德·特朗普总统周六签署了一项行政令，他称该命令“指示FDA加快对部分已被指定为突破性疗法的致幻剂的审查”。
“我今天签署的这项行政令，确实是一个历史性时刻，”特朗普说道。“这些治疗手段目前正处于临床试验的高级阶段，以确保它们对美国患者既安全又有效。”
总统表示，该行政令将落实“历史性改革，大幅加快基于致幻剂的新型医学研究和治疗手段的可及性”。
“在许多情况下，这些实验性治疗手段已经展现出改变人生的潜力，能够帮助那些饱受严重精神疾病和抑郁症折磨的患者，包括我们敬爱的退伍军人，”特朗普在谈到退伍军人自杀率时说道。
退伍军人跨境获取违禁致幻疗法，战后生活迎来转变
2026年4月18日周六，在华盛顿特区白宫椭圆形办公室，唐纳德·特朗普总统举着一项授予伊博加因药物许可的行政令。（朱莉娅·德马雷·尼基森/美联社）
“而美好的一点是，我们其实提前推进了这项工作，但相关研究已经进行了相当长一段时间。不过你知道，通常这类研究无论结果如何，都不会有任何进展，但我们正在改变这一现状。这项行政令将清除不必要的官僚障碍，改善FDA和退伍军人事务部之间的数据共享，并推动对任何获得FDA批准的致幻剂进行快速重新归类，”特朗普继续说道。
总统表示：“2024年，斯坦福大学的一项研究显示，30名患有创伤性脑损伤的特种部队退伍军人接受了——也就是伊博加因治疗——伊博加因，记住这个名字，”他指出，这些患者“在一个月内抑郁和焦虑症状减轻了80%至90%”。
“在德克萨斯州，共和党领导人已经承诺为伊博加因研究提供5000万美元资金。而今天，联邦政府也将自行投入5000万美元用于相关研究。这笔资金昨晚刚刚获批，”特朗普宣布。
“我们还将根据‘尝试权’法案，为重症患者开设一条伊博加因给药的通道，”特朗普说。
“今天的这项行政令将确保那些饱受衰弱症状折磨的人们终于有机会重拾生活，过上更幸福的生活，真正过上更幸福的生活，”他补充道。
研究显示：痴呆风险或与你的心态和人生态度有关
一罐磨碎的伊博加因粉末。（直武卡迪/法新社通过盖蒂图片社）
发表在《慢性应激》期刊上的一篇论文称，伊博加因是一种“具有精神活性的吲哚生物碱，提取自雨林灌木伊博加树，几个世纪以来在中非地区用于入会仪式”。
“据报道，伊博加因治疗能够缓解一系列情绪和焦虑症状，并且据自我报告，可改善物质使用障碍患者的认知功能。在治疗过程中，伊博加因能够唤起并重新处理创伤记忆，并带来具有治疗意义和精神层面、自传体内容的有意义幻觉，这对解决创伤后应激障碍相关的心理问题至关重要，”文章补充道。
“根据这项行政令，美国卫生与公众服务部将加快新型心理健康治疗手段的研究审批和可及性，包括伊博加因等致幻疗法。我们采取这一决定性举措，以应对我国面临的最紧迫的公共卫生挑战之一——心理健康危机，”美国卫生与公众服务部部长小罗伯特·F·肯尼迪说道。“超过1400万美国人患有严重精神疾病，每4名成年人中就有1人每年可被诊断出精神障碍。过去二十年来，自杀率上升了30%以上，近年来更是达到新的峰值。自2001年以来，每年有超过6000名退伍军人自杀。我们因自杀失去的退伍军人人数远超战场上的阵亡人数。”
“与此同时，数百万患有抑郁症、创伤后应激障碍、成瘾症和其他疾病的美国人对现有治疗方法没有反应。我们理应竭尽所能，减轻退伍军人因服役带来的情感和心理健康创伤，”他补充道。
周六与特朗普一同出现在椭圆形办公室的播客主持人乔·罗根也说道：“我想说，我今天来到这里是因为我左边的这位人士，布莱恩·哈伯德【非营利组织‘美国人支持伊博加因’的首席执行官】和前德克萨斯州州长里克·佩里曾做客我的播客。”
2026年4月18日周六，在华盛顿特区白宫椭圆形办公室，唐纳德·特朗普总统在签署行政令前发表讲话。（朱莉娅·德马雷·尼基森/美联社）
点击此处获取福克斯新闻APP
“他们向我讲述了这种药物的影响力。那次对话之后，数百万人有机会听到他们的故事，听到所有通过该疗法获得人生转变的不同人士的经历，”罗根说。
格雷格·诺曼是福克斯新闻数字频道的记者。
Trump signs executive order directing FDA to review psychedelics designated as breakthrough therapy drugs
2026-04-18 09:25 EDT / Fox News
Executive order implements ‘historic reforms to dramatically accelerate access to new medical research and treatments based on psychedelic drugs,’ Trump says
By Greg Norman-Diamond Fox News
Published April 18, 2026 9:25am EDT | Updated April 18, 2026 10:03am EDT
Trump fast-tracks FDA psychedelics review after Joe Rogan spotlights veterans’ mental health
President Donald Trump signed an executive order directing the FDA to expedite review of psychedelics already designated as breakthrough therapy drugs. Joe Rogan and others spoke in the Oval Office about the benefits to veterans’ mental health.
NEW You can now listen to Fox News articles!
Listen to this article
4 min
President Donald Trump signed an executive order Saturday that he said “directs the FDA to expedite their review of certain psychedelics already designated as breakthrough therapy drugs.”
“The executive order I’m signing, we’re actually signing the executive order today, is really a moment,” Trump said. “These treatments are currently in the advanced stages of clinical trials to ensure that they’re both safe and effective for the American patients.”
The president said the executive order would implement “historic reforms to dramatically accelerate access to new medical research and treatments based on psychedelic drugs.”
“In many cases, these experimental treatments have shown life-changing potential for those suffering from severe mental illness and depression, including our cherished veterans,” Trump said, citing the veteran suicide rate.
VETERANS CROSS BORDER FOR FORBIDDEN PSYCHEDELIC TREATMENT THAT’S CHANGING LIVES AFTER COMBAT
President Donald Trump holds up an executive order giving Ibogaine drug clearance in the Oval Office of the White House, on Saturday, April 18, 2026, in Washington, D.C.(Julia Demaree Nikhinson/AP)
“And the nice part is we’re actually doing this early, but it has been going on. Research has been going on for quite some time. But, you know, usually with things like this, nothing ever happens, no matter how the research ends up, but we’re changing that. This order will clear away unnecessary bureaucratic hurdles, improve data sharing among the FDA and the Department of Veterans Affairs, and facilitate fast rescheduling of any psychedelic drugs that become FDA approved,” Trump continued.
The president said “in 2024, a study from Stanford University, 30 special operation veterans with traumatic brain injuries underwent — it’s called ibogaine treatment — ibogaine, remember the name,” noting that they “experienced an 80 to 90% reduction in symptoms of depression and anxiety within one month.”
“In Texas, Republican leaders have already committed $50 million to the ibogaine research. And today, the federal government is making a $50 million research investment in its own. And so that was just approved just last night,” Trump announced.
“We’re also opening a pathway for ibogaine to be administered to desperately ill patients under the right to try law,” Trump said.
“Today’s order will ensure that people suffering from debilitating symptoms might finally have a chance to reclaim their lives and lead a happier life, just lead a happier life,” he added.
DEMENTIA RISK COULD BE TIED TO YOUR MINDSET AND OUTLOOK ON LIFE, STUDY SUGGESTS
A jar filled with finely ground iboga powder.(Nao Mukadi/AFP via Getty Images)
A paper published in the journal Chronic Stress said ibogaine is a “psychoactive indole alkaloid which is extracted from the Tabernanthe iboga rainforest shrub and has been used for centuries in Central Africa for initiatory rituals.”
“Ibogaine treatment is reported to alleviate a spectrum of mood and anxiety symptoms and is associated with self-reported improvements in cognitive functioning in individuals with substance-use disorders. During treatment, ibogaine allows the evocation and reprocessing of traumatic memories and occasions therapeutic and meaningful visions of spiritual and autobiographical content, which are of central relevance in addressing PTSD-related psychological content,” it added.
“Under the executive order, HHS will accelerate research approval and access to new mental health treatments, including psychedelic therapies such as ibogaine. We’re taking this decision, this decisive step to confront one of the most urgent public health challenges facing our nation – the mental health crisis,” Health and Human Services Secretary Robert F. Kennedy Jr. said. “More than 14 million Americans live with serious mental illness, and 1 in 4 adults experiences a diagnosable disorder each year. Suicide has risen by more than 30% over the past two decades, with another peak in recent years. Among veterans, more than 6,000 died by suicide each year since 2001. We have lost far more veterans to suicide than to combat.”
“At the same time, millions of Americans living with depression, PTSD, addiction and other conditions do not respond to existing treatments. We owe it to our warfighters and veterans to turn over every stone to alleviate the emotional and mental health blowback from their deployments,” he added.
Podcaster Joe Rogan, who was in the Oval Office with Trump on Saturday, also said “I want to say that I’m here because of the man to my left, Bryan Hubbard [CEO of nonprofit Americans for Ibogaine] and former Texas Gov. Rick Perry came on my podcast.”
President Donald Trump speaks before signing an executive order in the Oval Office of the White House, on Saturday, April 18, 2026, in Washington.(Julia Demaree Nikhinson/AP)
CLICK HERE TO GET THE FOX NEWS APP
“They told me how impactful this medicine is. And having that conversation with them, millions of people got a chance to hear their story, hear the stories of all the different people that have had life-changing experiences from it,” Rogan said.
Greg Norman is a reporter at Fox News Digital.